News

Find News

Filter articles

Applied Filters

Showing 741 to 750 of 919 results

Purdue moves to block oxycodone drug

US01-04-2015

Purdue Pharma has sued Collegium Pharmaceutical for allegedly infringing four of its patents relating to extended release painkiller OxyContin.

Hospira targeted in generic Aloxi patent infringement case

US25-03-2015

Cancer treatment company Helsinn and pharmaceutical company Roche have sued Hospira for allegedly infringing five patents covering intravenous anti-nausea drug Aloxi.

Federal Circuit agrees that Exela infringed Ofirmev patents

US24-03-2015

The US Court of Appeals for the Federal Circuit yesterday upheld a district court's decision that pharmaceutical company Exela infringed two patents covering Cadence Pharmaceuticals’s injectable Ofirmev, used for pain relief.

BMS sues Mylan to block Reyataz generic

US20-03-2015

Bristol-Myers Squibb has sued generic drug maker Mylan for allegedly infringing a patent covering its HIV drug Reyataz.

ITMA spring conference: IP has ‘dirty’ connotations, says GSK

EU19-03-2015

Intellectual property is still seen as a “dirty term” in the EU, the assistant general counsel of pharmaceutical company GlaxoSmithKline has claimed.

Delaware court rules on claim construction in Banzel patent row

US18-03-2015

A US district court yesterday gave its opinion on how a group of disputed patent claims must be construed in a patent infringement case between Eisai and Novartis and several generic drug makers.

CJEU clarifies rules on combination SPCs

UK13-03-2015

An Advocate General in the Court of Justice of the European Union, Niilo Jääskinen, has clarified how the regulation for supplementary protection certificates should be interpreted concerning medicinal products made with a combination of active ingredients.

Otsuka sues Wockhardt to protect Abilify

US11-03-2015

Japanese company Otsuka Pharmaceutical has sued drugs company Wockhardt for patent infringement at the US District Court for the District of New Jersey.

US Supreme Court refuses to hear Tamiflu ‘double patenting’ case

US10-03-2015

The US Supreme Court yesterday refused to hear a case between Californian pharmaceutical company Gilead and India-based Natco that concerns ‘double patenting’.

German court rules against Eli Lilly in Alimta patent case

EU, Germany09-03-2015

The German Court of Appeal has ruled that Indianapolis-based Eli Lilly’s European “vitamin regimen” patent for lung cancer injection Alimta would not be infringed by Actavis’s generic version.

Showing 741 to 750 of 919 results

LSIPR